Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Debu, Tripathy"'
Autor:
Sonal Shad, William Fraser Symmans, Debu Tripathy, Lamorna Brown-Swigart, LJ Esserman, Jane Perlmutter, V. Valero, Rebekah Gould, Gregor Krings, Judy C. Boughey, Jodi M. Carter, M. van der Noordaa, Gillian L. Hirst, L.J. van 't Veer, Christina Yau, Douglas Yee, Lajos Pusztai, Tufia C. Haddad, Kathy S. Albain, Molly Klein, Lili Du, MC Liu, Rita Nanda, Claudine Isaacs, Richard Schwab, Amy Jo Chien, Donald A. Berry, Rachel M. Layman, AM DeMichele, Isabelle Bedrosian, Sara J. Venters, Nola M. Hylton
Publikováno v:
Annals of Oncology. 32:642-651
BACKGROUND We proposed that a test for sensitivity to the adjuvant endocrine therapy component of treatment for patients with stage II-III breast cancer (SET2,3) should measure transcription related to estrogen and progesterone receptors (SETER/PR in
Autor:
Amy L. Delson, Gillian L. Hirst, Amy Jo Chien, Bernhard Zimmermann, L.J. van 't Veer, Alexey Aleshin, Denise M. Wolf, Svetlana Shchegrova, Raheleh Salari, AM DeMichele, Laura J. Esserman, H. Pawar, Mark Jesus M. Magbanua, Himanshu Sethi, Antony Tin, S Asare, MC Liu, Lamorna Brown Swigart, Debu Tripathy, Maggie C. Louie, C-Hj Lin, Paul Billings, Christina Yau, H.-T. Wu
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology, vol 32, iss 2
Ann Oncol
Ann Oncol
Author(s): Magbanua, MJM; Swigart, LB; Wu, H-T; Hirst, GL; Yau, C; Wolf, DM; Tin, A; Salari, R; Shchegrova, S; Pawar, H; Delson, AL; DeMichele, A; Liu, MC; Chien, AJ; Tripathy, D; Asare, S; Lin, C-HJ; Billings, P; Aleshin, A; Sethi, H; Louie, M; Zimm
Autor:
Akshara Singareeka Raghavendra, Raymond Sawaya, Fuchenchu Wang, Nuhad K. Ibrahim, Limin Hsu, Eric A. Strom, Debu Tripathy, Jing Li, Chao Gao, Dima Suki
Publikováno v:
International Journal of Cancer. 148:961-970
Outcomes of treatments for patients with breast cancer brain metastasis (BCBM) remain suboptimal, especially for systemic therapy. To evaluate the effectiveness of systemic and local therapy (surgery [S], stereotactic radiosurgery [SRS] and whole bra
Autor:
Debu Tripathy, Takeo Fujii, James P. Long, Sudpreeda Chainitikun, Toshiaki Iwase, Ruben Rodriguez-Bautista, Naoto T. Ueno
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Combinations of endocrine therapy (ET) and targeted therapy (CDK4/6 or mTOR inhibitors) are standard of care for HR+/HER2- metastatic breast cancer (MBC). When ET is not effective, chemotherapy is commonly used. However, clinical outcomes of
Autor:
Helen Piwnica-Worms, Jennifer K. Litton, Banu Arun, Beatriz E. Adrada, Haven R. Garber, Gaiane M. Rauch, Debu Tripathy, Senthil Damodaran, Elizabeth A. Mittendorf, Vicente Valero, Rashmi Krishna Murthy, Fraser Symmans, Stacy L. Moulder, Lei Huo, Alastair M. Thompson, Naoto T. Ueno, Nuhad K. Ibrahim, Rosalind P. Candelaria, Bora Lim
Publikováno v:
Cancer Research. 80:P2-16
BACKGROUND: Current treatment for early stage triple negative breast cancer (TNBC) includes neoadjuvant systemic chemotherapy (NAST), which is used to assess disease biology and the need for adjuvant treatment in case of residual disease at the time
Autor:
Evan N. Cohen, Alexandre Reuben, Naoto T. Ueno, James M. Reuben, Angela Alexander, Kumiko Kida, Charla A. Parker, Hui Gao, Bora Lim, S Tin, Debu Tripathy, Vicente Valero
Publikováno v:
Cancer Research. 80:P3-09
Background: Inflammatory breast cancer (IBC) and triple negative breast cancer (TNBC) are more aggressive than other breast cancer subtypes, and up until recently lacked therapy options that maintain acceptable quality of life. While chemotherapy is
Autor:
Denise M. Wolf, Laura van 't Veer, Alexey Aleshin, Amy L. Delson, Bernhard Zimmermann, Lamorna Brown Swigart, Mark Jesus M. Magbanua, Wen Li, A. Jo Chien, Nola M. Hylton, Jessica Gibbs, Debu Tripathy, Gillian L. Hirst, Laura J. Esserman, Ekaterina Kalashnikova, David C. Newitt, Christina Yau
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
NPJ Breast Cancer
NPJ breast cancer, vol 7, iss 1
NPJ Breast Cancer
NPJ breast cancer, vol 7, iss 1
We investigated whether serial measurements of circulating tumor DNA (ctDNA) and functional tumor volume (FTV) by magnetic resonance imaging (MRI) can be combined to improve prediction of pathologic complete response (pCR) and estimation of recurrenc
Autor:
Paul Wheatley-Price, Saúl Campos-Gómez, I Diaz-Padilla, Y-H Im, Gareth Hughes, V Srimuninnimit, Aditya Bardia, Marco Colleoni, Faye Su, Debu Tripathy, KH Jung, M. Miller, David Taylor, Sherko Kümmel
Publikováno v:
Cancer Research. 79:PD2-08
Background: In the MONALEESA-7 study (NCT02278120), ribociclib (RIB) + a non-steroidal aromatase inhibitor (NSAI)/tamoxifen (TAM) + goserelin (GOS) significantly improved progression-free survival (PFS) vs placebo (PBO) + NSAI/TAM + GOS in premenopau
Autor:
Rie K. Tahara, JM Reuben, Babita Saigal, Beth Chasen, Diane Liu, Gabriel N. Hortobagyi, T Fujii, Debu Tripathy, Senthil Damodaran, Bora Lim, NT Ueno, Hui Gao, Nuhad K. Ibrahim, Anthony Lucci, Yu Shen
Publikováno v:
Cancer Research. 79:P1-18
Background: Radium-223 dichloride (Ra-223) is a targeted alpha particle-based radiotherapeutic that has a localized cytotoxic effect on bone metastases. We sought to determine whether the circulating tumor cell (CTC) count and the presence of CTCs in
Autor:
Kumiko Kida, Aysegul A. Sahin, Bora Lim, Debu Tripathy, Huey Liu, June G. Lee, NT Ueno, Ravi Murthy
Publikováno v:
Cancer Research. 79:P3-10
Background: Although tremendous progress has been achieved with targeted therapy for HER2-positive (HER2+) metastatic breast cancer, most advanced tumors eventually develop resistance. Improving our understanding of mechanisms of resistance to anti-H